• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

5-羟色胺3受体拮抗剂呕必停（昂丹司琼）作为癌症患者细胞毒性治疗期间预防恶心和呕吐的药物

[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].

作者信息

Perevodchikova N I, Volkova M A, Gorbunova V A, Manziuk L V, Marenich A F, Smirnova N B

出版信息

Ter Arkh. 1996;68(2):30-4.

PMID:8771653
Abstract

The authors describe regimens of Zofran application convenient in oncological practice to prevent nausea and vomiting in patients receiving cytostatic drugs. It is well tolerated and low toxic.

摘要

作者描述了在肿瘤学实践中方便使用的佐芬应用方案，以预防接受细胞毒性药物治疗的患者出现恶心和呕吐。它耐受性良好且毒性低。

相似文献

1
[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].5-羟色胺3受体拮抗剂呕必停（昂丹司琼）作为癌症患者细胞毒性治疗期间预防恶心和呕吐的药物
Ter Arkh. 1996;68(2):30-4.
2
[Evaluation of the anti-emetic effectiveness of two drug formulations of Ondansetron in combined chemotherapy for children with malignant tumors].
Vopr Onkol. 1999;45(4):424-8.
3
Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.输注帕洛诺司琼加地塞米松预防化疗引起的恶心和呕吐。
J Support Oncol. 2006 Oct;4(9):467-71.
4
Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.在接受中度致吐性化疗的乳腺癌患者中，短暂（30秒推注）静脉注射格拉司琼与标准（15分钟）静脉注射昂丹司琼的安全性和止吐疗效相当。
Cancer J Sci Am. 1998 Jan-Feb;4(1):52-8.
5
Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.口服格拉司琼加地塞米松与静脉注射昂丹司琼加地塞米松控制中/重度致吐性化疗引起的恶心和呕吐的疗效及安全性比较。
Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):729-36.
6
[Novel pharmacologic form of ondansetron (Zofran)--lingual tablets in the prevention of cytostatic chemotherapy-induced loss of appetite, nausea and vomiting].[昂丹司琼（枢复宁）的新型药理学剂型——舌下片预防细胞毒性化疗引起的食欲不振、恶心和呕吐]
Vopr Onkol. 2003;49(4):505-9.
7
Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
Haematologia (Budap). 1998;29(1):25-31.
8
The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.地塞米松在减轻化疗引起的恶心和呕吐方面的影响。
J BUON. 2007 Apr-Jun;12(2):245-52.
9
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.昂丹司琼，一种5 - HT3受体拮抗剂，用于治疗儿童抗肿瘤药物引起的恶心和呕吐。
J Med. 1993;24(2-3):161-70.
10
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?铂类化疗引起的急性恶心和呕吐的管理：是否存在更优的5-羟色胺受体拮抗剂？
J Oncol Pharm Pract. 2007 Jun;13(2):69-75. doi: 10.1177/1078155207078137.